Blessing Danso , Yang Fengling , Xiaoyu Hua , Jinyu Zhang , Jingbo Chen , Yuan Yao , Marina Pozzolini , Fei Wang , Liang Xiao , Huang Ruixue
{"title":"从水母多肽中提取金属蛋白酶(MMPs)和磷脂酶的潜在抑制剂:计算机药代动力学和分子对接研究","authors":"Blessing Danso , Yang Fengling , Xiaoyu Hua , Jinyu Zhang , Jingbo Chen , Yuan Yao , Marina Pozzolini , Fei Wang , Liang Xiao , Huang Ruixue","doi":"10.1016/j.toxicon.2025.108421","DOIUrl":null,"url":null,"abstract":"<div><div>Jellyfish stings, especially from <em>Nemopilema nomurai</em>, pose serious health risks due to its venom toxins like metalloproteinases (MMPs) and phospholipases A2 (PLAs A2). Thes toxin can induce severe reactions such as pain, tissue necrosis, inflammation, and in extreme cases, cardiac arrest. While the exact mechanisms of toxicity are not fully understood, MMPs and PLA2 enzymes are known to contribute significantly to tissue damage and inflammation. Thus, the inhibition of these toxins could reduce venom toxicity and provide new treatment options for jellyfish envenomation. This study utilized pharma informatic to evaluate <em>Nemopilema nomurai</em> jellyfish-derived peptides against <em>Nemopilema nomurai</em> venom toxins (metalloproteinase and phospholipase). After profiling absorption, distribution, metabolism, excretion, and toxicity (ADMET) parameters, two peptides, DN26779_N and DN26779_Q, were selected for docking analysis. DN26779_N exhibited higher binding energy to metalloproteinase (−13.3), and phospholipase (−12.6) than DN26779_Q. Molecular dynamics simulations confirmed the stability of these interactions, driven by hydrophobic affinity and hydrogen bonding. Overall, DN26779_N and DN26779_Q demonstrate significant potential as inhibitors of metalloproteinase, and phospholipase A2, presenting promising therapeutic avenues for treating and addressing jellyfish envenomation.</div></div>","PeriodicalId":23289,"journal":{"name":"Toxicon","volume":"263 ","pages":"Article 108421"},"PeriodicalIF":2.6000,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Potential inhibitors of metalloproteinases (MMPs) and phospholipases from Nemopilema nomurai jellyfish peptides: An in-silico pharmacokinetics and molecular docking studies\",\"authors\":\"Blessing Danso , Yang Fengling , Xiaoyu Hua , Jinyu Zhang , Jingbo Chen , Yuan Yao , Marina Pozzolini , Fei Wang , Liang Xiao , Huang Ruixue\",\"doi\":\"10.1016/j.toxicon.2025.108421\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Jellyfish stings, especially from <em>Nemopilema nomurai</em>, pose serious health risks due to its venom toxins like metalloproteinases (MMPs) and phospholipases A2 (PLAs A2). Thes toxin can induce severe reactions such as pain, tissue necrosis, inflammation, and in extreme cases, cardiac arrest. While the exact mechanisms of toxicity are not fully understood, MMPs and PLA2 enzymes are known to contribute significantly to tissue damage and inflammation. Thus, the inhibition of these toxins could reduce venom toxicity and provide new treatment options for jellyfish envenomation. This study utilized pharma informatic to evaluate <em>Nemopilema nomurai</em> jellyfish-derived peptides against <em>Nemopilema nomurai</em> venom toxins (metalloproteinase and phospholipase). After profiling absorption, distribution, metabolism, excretion, and toxicity (ADMET) parameters, two peptides, DN26779_N and DN26779_Q, were selected for docking analysis. DN26779_N exhibited higher binding energy to metalloproteinase (−13.3), and phospholipase (−12.6) than DN26779_Q. Molecular dynamics simulations confirmed the stability of these interactions, driven by hydrophobic affinity and hydrogen bonding. Overall, DN26779_N and DN26779_Q demonstrate significant potential as inhibitors of metalloproteinase, and phospholipase A2, presenting promising therapeutic avenues for treating and addressing jellyfish envenomation.</div></div>\",\"PeriodicalId\":23289,\"journal\":{\"name\":\"Toxicon\",\"volume\":\"263 \",\"pages\":\"Article 108421\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-05-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Toxicon\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0041010125001953\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Toxicon","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0041010125001953","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Potential inhibitors of metalloproteinases (MMPs) and phospholipases from Nemopilema nomurai jellyfish peptides: An in-silico pharmacokinetics and molecular docking studies
Jellyfish stings, especially from Nemopilema nomurai, pose serious health risks due to its venom toxins like metalloproteinases (MMPs) and phospholipases A2 (PLAs A2). Thes toxin can induce severe reactions such as pain, tissue necrosis, inflammation, and in extreme cases, cardiac arrest. While the exact mechanisms of toxicity are not fully understood, MMPs and PLA2 enzymes are known to contribute significantly to tissue damage and inflammation. Thus, the inhibition of these toxins could reduce venom toxicity and provide new treatment options for jellyfish envenomation. This study utilized pharma informatic to evaluate Nemopilema nomurai jellyfish-derived peptides against Nemopilema nomurai venom toxins (metalloproteinase and phospholipase). After profiling absorption, distribution, metabolism, excretion, and toxicity (ADMET) parameters, two peptides, DN26779_N and DN26779_Q, were selected for docking analysis. DN26779_N exhibited higher binding energy to metalloproteinase (−13.3), and phospholipase (−12.6) than DN26779_Q. Molecular dynamics simulations confirmed the stability of these interactions, driven by hydrophobic affinity and hydrogen bonding. Overall, DN26779_N and DN26779_Q demonstrate significant potential as inhibitors of metalloproteinase, and phospholipase A2, presenting promising therapeutic avenues for treating and addressing jellyfish envenomation.
期刊介绍:
Toxicon has an open access mirror Toxicon: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review. An introductory offer Toxicon: X - full waiver of the Open Access fee.
Toxicon''s "aims and scope" are to publish:
-articles containing the results of original research on problems related to toxins derived from animals, plants and microorganisms
-papers on novel findings related to the chemical, pharmacological, toxicological, and immunological properties of natural toxins
-molecular biological studies of toxins and other genes from poisonous and venomous organisms that advance understanding of the role or function of toxins
-clinical observations on poisoning and envenoming where a new therapeutic principle has been proposed or a decidedly superior clinical result has been obtained.
-material on the use of toxins as tools in studying biological processes and material on subjects related to venom and antivenom problems.
-articles on the translational application of toxins, for example as drugs and insecticides
-epidemiological studies on envenoming or poisoning, so long as they highlight a previously unrecognised medical problem or provide insight into the prevention or medical treatment of envenoming or poisoning. Retrospective surveys of hospital records, especially those lacking species identification, will not be considered for publication. Properly designed prospective community-based surveys are strongly encouraged.
-articles describing well-known activities of venoms, such as antibacterial, anticancer, and analgesic activities of arachnid venoms, without any attempt to define the mechanism of action or purify the active component, will not be considered for publication in Toxicon.
-review articles on problems related to toxinology.
To encourage the exchange of ideas, sections of the journal may be devoted to Short Communications, Letters to the Editor and activities of the affiliated societies.